1-6 of 6
Kosmas Daskalakis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Longitudinal Changes in Ki-67 Indices in Small-Intestinal Neuroendocrine Tumours and Their Impact on Survival

Open Access
Subject Area:
Endocrinology , Neurology and Neuroscience
Kosmas Daskalakis, Marina Tsoli, Maria Wedin, Beata Kos-Kudla, Angelika Kogut, Raj Srirajaskanthan, Dominique S.V.M. Clement, Georgios Giovos, Martin O. Weickert, Gregory Kaltsas
Journal: Neuroendocrinology
Neuroendocrinology (2025) 115 (5): 402–410.
https://doi.org/10.1159/000541101
Published Online: 27 August 2024
View articletitled, Longitudinal Changes in Ki-67 Indices in Small-Intestinal Neuroendocrine Tumours and Their Impact on Survival
Open the PDF for Longitudinal Changes in Ki-67 Indices in Small-Intestinal Neuroendocrine Tumours and Their Impact on Survival in another window
Journal Articles

Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms

Available to Purchase
Subject Area:
Endocrinology , Neurology and Neuroscience
Eleftherios Chatzellis, Anna Angelousi, Kosmas Daskalakis, Marina Tsoli, Krystallenia I. Alexandraki, Ewa Wachuła, Amichay Meirovitz, Ofra Maimon, Simona Grozinsky-Glasberg, David Gross, Beata Kos-Kudła, Anna Koumarianou, Gregory Kaltsas
Journal: Neuroendocrinology
Neuroendocrinology (2019) 109 (4): 333–345.
https://doi.org/10.1159/000500135
Published Online: 19 November 2019
View articletitled, Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms
Open the PDF for Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms in another window
Journal Articles

Authors’ Response to the Letter by Lamarca et al. Entitled “Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration” Regarding “Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms”

Available to Purchase
Subject Area:
Endocrinology , Neurology and Neuroscience
Eleftherios Chatzellis, Kosmas Daskalakis, Anna Angelousi, Marina Tsoli, Krystallenia I. Alexandraki, Ewa Wachula, Amichay Meirovitz, Ofra Maimon, Simona Grozinsky-Glasberg, David Gross, Beata Kos-Kudła, Anna Koumarianou, Gregory Kaltsas
Journal: Neuroendocrinology
Neuroendocrinology (2020) 110 (1-2): 158–160.
https://doi.org/10.1159/000503999
Published Online: 10 October 2019
View articletitled, Authors’ Response to the Letter by Lamarca et al. Entitled “Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration” Regarding “Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms”
Open the PDF for Authors’ Response to the Letter by Lamarca et al. Entitled “Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration” Regarding “Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms” in another window
Journal Articles

Lung Metastases in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Neoplasms: An Appraisal of the Validity of Thoracic Imaging Surveillance

Available to Purchase
Subject Area:
Endocrinology , Neurology and Neuroscience
Kosmas Daskalakis, Marina Tsoli, Raj Srirajaskanthan, Eleftherios Chatzellis, Krystallenia Alexandraki, Anna Angelousi, Michail Pizanias, Harpal Randeva, Gregory Kaltsas, Martin O. Weickert
Journal: Neuroendocrinology
Neuroendocrinology (2019) 108 (4): 308–316.
https://doi.org/10.1159/000497183
Published Online: 23 January 2019
View articletitled, Lung Metastases in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Neoplasms: An Appraisal of the Validity of Thoracic Imaging Surveillance
Open the PDF for Lung Metastases in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Neoplasms: An Appraisal of the Validity of Thoracic Imaging Surveillance in another window
Journal Articles

Lung Carcinoids: Long-Term Surgical Results and the Lack of Prognostic Value of Somatostatin Receptors and Other Novel Immunohistochemical Markers

Available to Purchase
Subject Area:
Endocrinology , Neurology and Neuroscience
Kosmas Daskalakis, Gregory Kaltsas, Kjell Öberg, Apostolos V. Tsolakis
Journal: Neuroendocrinology
Neuroendocrinology (2019) 107 (4): 355–365.
https://doi.org/10.1159/000493944
Published Online: 23 September 2018
View articletitled, Lung Carcinoids: Long-Term Surgical Results and the Lack of Prognostic Value of Somatostatin Receptors and Other Novel Immunohistochemical Markers
Open the PDF for Lung Carcinoids: Long-Term Surgical Results and the Lack of Prognostic Value of Somatostatin Receptors and Other Novel Immunohistochemical Markers in another window
Journal Articles

DcR3, TFF3, and Midkine Are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors

Available to Purchase
Subject Area:
Endocrinology , Neurology and Neuroscience
Katarina Edfeldt, Kosmas Daskalakis, Christofer Bäcklin, Olov Norlén, Eva Tiensuu Janson, Gunnar Westin, Per Hellman, Peter Stålberg
Journal: Neuroendocrinology
Neuroendocrinology (2017) 105 (2): 170–181.
https://doi.org/10.1159/000452891
Published Online: 09 November 2016
View articletitled, DcR3, TFF3, and Midkine Are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors
Open the PDF for DcR3, TFF3, and Midkine Are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors in another window